Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperhydration to Improve Kidney Outcomes in Children With Shiga Toxin-Producing E. Coli Infection: A Multinational Embedded Cluster Crossover Randomized Trial

NCT05219110 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT05219110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05219110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperhydration to Improve Kidney Outcomes in Children With Shiga Toxin-Producing E. Coli Infection: A Multinational Embedded Cluster Crossover Randomized Trial
Lead sponsor
University of Calgary
Phase
Not applicable
Overall status
Recruiting
Start date
September 29, 2022
Completion date
August 31, 2028
Enrollment
1,040 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

hemolytic-uremic syndrome, shiga toxin-producing escherichia coli (e. coli) infection